LONDON (Reuters) – Britain medicines regulator said on Monday it would aim to make a decision on Pfizer and BioNTech’s COVID-19 vaccine candidate “in the shortest time possible” after receiving additional data about the shot.
“It is our job now to rigorously assess these data and the evidence submitted on the vaccine’s safety, quality and effectiveness,” said June Raine, chief executive of Britain’s Medicines and Healthcare products Regulatory Agency.
“As we have received this data through a rolling review, we have already started our analysis and will aim to make a decision in the shortest time possible, without compromising the thoroughness of our review.”
(Reporting by Michael Holden; editing by Sarah Young)
